← Open Payments lookup

ANALVIS CUESTA: Open Payments

NPI 1306306428 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,377 in 156 payments from 38 companies in 2025. Trend: 2023 $1,275 · 2024 $2,715 · 2025 $4,377

Food & beverage: $3,234Long term medical supply or device loan: $897Education: $245
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation19$1,125
AstraZeneca Pharmaceuticals LP16$379
PFIZER INC.13$287
Merck Sharp & Dohme LLC8$201
ABBVIE INC.7$181
Daiichi Sankyo Inc.8$168
Janssen Biotech, Inc.7$150
Incyte Corporation5$147
GENZYME CORPORATION5$143
JAZZ PHARMACEUTICALS INC.4$138

Products named: KISQALI, ENHERTU, KEYTRUDA, SARCLISA, ZEPZELCA, VENCLEXTA, BRUKINSA, IBRANCE.

Industry payments across GA — which companies pay providers there.